Global Systemic Aspergillosis and Systemic Candidiasis Research Report 2024-2030 Featuring Sanofi, Cipla, Pfizer, GSK, Novartis, Bayer, Merck, F. Hoffmann-La Roche, Abbott, Gilead Sciences
May 24, 2024 06:32 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By...
Global Antifungal Drugs Market 2023-2030: Azoles-based Treatment Shows Considerable Efficacy
August 14, 2023 08:38 ET
|
Research and Markets
Dublin, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The "Antifungal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030" report has been added to ...
Sepsis Management Analysis, 2020 Report - Treatments Focused Towards Antibiotics, Inhibitors, Antibodies, Peptides, Recombinant Proteins, Antibacterial, Antifungal, Antivirals, Vaccines, & Probiotics
January 12, 2021 09:53 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Analysing Sepsis Management Part II: Treatments" report has been added to ResearchAndMarkets.com's offering. This research study begins by...
Candidemia Market Insights, Epidemiology, and Market Forecast Report 2017-2030
January 12, 2021 09:08 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Candidemia - Market Insights, Epidemiology, and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets.com's offering. The...